144 related articles for article (PubMed ID: 136871)
1. Experimental studies of tumor immunotherapy. II. Tumor immunotherapy following tumor extirpation.
Hayashi S
Acta Med Okayama; 1976 Jun; 30(3):197-208. PubMed ID: 136871
[TBL] [Abstract][Full Text] [Related]
2. Experimental studies of tumor immunotherapy. I. Macrophage migration inhibitory activity as an immunological parameter.
Hayashi S
Acta Med Okayama; 1976 Apr; 30(2):95-106. PubMed ID: 135489
[TBL] [Abstract][Full Text] [Related]
3. Effect of Myobacterium bovis (strain Bacillus Calmette-Guérin) on macrophage production by the bone marrow of tumor-bearing mice.
Fisher B; Taylor S; Levine M; Saffer E; Fisher ER
Cancer Res; 1974 Jul; 34(7):1668-70. PubMed ID: 4599359
[No Abstract] [Full Text] [Related]
4. Nonspecific resistance to tumor allograft.
Rejthar A; Wotke J; Rejtharová A; Jasková J
Neoplasma; 1975; 22(3):273-8. PubMed ID: 1099469
[TBL] [Abstract][Full Text] [Related]
5. Activated macrophages and the antitumor action of BCG.
Alexander P
Natl Cancer Inst Monogr; 1973 Dec; 39():127-33. PubMed ID: 4595313
[No Abstract] [Full Text] [Related]
6. Macrophage function in tumor-bearing mice: tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG.
Meltzer MS; Stevenson MM
J Immunol; 1977 Jun; 118(6):2176-81. PubMed ID: 325142
[No Abstract] [Full Text] [Related]
7. Immunotherapy of guinea pig cancer with BCG.
Zbar B
Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
[No Abstract] [Full Text] [Related]
8. Some immunologically based reactions that can cause the regression of large tumor masses.
Alexander P
Natl Cancer Inst Monogr; 1976 Nov; 44():105-8. PubMed ID: 799755
[TBL] [Abstract][Full Text] [Related]
9. Destruction of tumor cells by BCG-activated alqolar macrophages.
Zwilling BS; Campolito LB
J Immunol; 1977 Sep; 119(3):838-41. PubMed ID: 330756
[TBL] [Abstract][Full Text] [Related]
10. Tumor immunity induced by BCG-tumor cell mixtures in syngeneic mice.
Tokunaga T; Kataoka T; Nakamura RM; Yamamoto S; Tanaka T
Jpn J Med Sci Biol; 1973 Apr; 26(2):71-85. PubMed ID: 4585343
[No Abstract] [Full Text] [Related]
11. Macrophage migration inhibition-activity after implantation of methylcholanthrene-induced sarcoma, Ehrlich ascites cancer or mouse ascites hepatoma-134 cancer cells in mice.
Yumura M
Acta Med Okayama; 1976 Feb; 30(1):37-48. PubMed ID: 184687
[TBL] [Abstract][Full Text] [Related]
12. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
[No Abstract] [Full Text] [Related]
13. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
[No Abstract] [Full Text] [Related]
14. [Tumor-specific immunotherapy: active immunotherapy by augmenting the induction of tumor-specific effector T cells through a T-T cell interaction mechanism].
Kosugi A; Fujiwara H; Hamaoka T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1527-35. PubMed ID: 6236750
[TBL] [Abstract][Full Text] [Related]
15. Immunological intervention in neoplasia.
Weiss DW
Johns Hopkins Med J Suppl; 1974; 3():131-56. PubMed ID: 4371312
[No Abstract] [Full Text] [Related]
16. Experimental and clinical trials with BCG immunotherapy.
Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
[No Abstract] [Full Text] [Related]
17. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG).
Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524
[No Abstract] [Full Text] [Related]
18. Induction of macrophage antitumor activity by a mycobacterial fraction. In vivo and in vitro studies.
Rashid G; Gittel H; Ben-Efraim S
Anticancer Res; 1994; 14(3A):1083-7. PubMed ID: 8074454
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterial cell wall components in tumor suppression and regression.
Ribi EE; Meyer TJ; Azuma I; Zbar B
Natl Cancer Inst Monogr; 1973 Dec; 39():115-9. PubMed ID: 4595311
[No Abstract] [Full Text] [Related]
20. An experimental model for immunotherapy of cancer.
Zbar B; Ribi E; Rapp HJ
Natl Cancer Inst Monogr; 1973 Dec; 39():3-9. PubMed ID: 4595326
[No Abstract] [Full Text] [Related]
[Next] [New Search]
